Clinical Research in the Developing World
Economic Incentives Drive Poor Ethical Oversight
The history of clinical trials covers a wide variety of scientific, ethical, and regulatory challenges. This paper delves into the present ethical complications of clinical research within developing countries. Here the definition of clinical research is broad, encompassing all trials aimed at evaluating a medical intervention. In principle, the paper focuses on the exploitative nature of clinical trials in developing countries.
I argue that there are two primary mechanisms of exploitation. The first is a lack of properly obtained informed consent and the second is an inequitable distribution of post-trial benefits. Next, I argue that the reason malpractice has ensued is due to economic incentives of governments involved, leading to weak ethical regulation, and as a consequence, ethical uncertainty among researchers. While there are other contributing factors, such as economic incentives of researchers and Contract Research Organizations (CROs), as well as racial discrimination that deserve attention, my paper does not discuss them.
Throughout the paper, I draw from research conducted and analyzed around the world. Case studies supporting my claims are drawn from India, the US, and China. Research regarding informed consent is drawn from all over Asia, Africa, and Latin America. The Asian countries include Thailand, India, the Philippines, and China, while the African countries include Kenya and Tanzania. Finally, the Latin American countries include Colombia, Brazil, and Mexico.
Copyright (c) 2021 Intersect: The Stanford Journal of Science, Technology, and Society
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).